Global Endoprosthesis Market-Forecast till 2027

Global Endoprosthesis Market-Forecast till 2027

$4450 – $6250

The global endoprosthesis market is anticipated to witness a healthy CAGR of 11.50% during the review period.

SKU: MRFR210212 Category: Tag:

Description

Global Endoprosthesis Market-Forecast till 2027

Endoprosthesis Market Overview

The global endoprosthesis market is anticipated to witness a healthy CAGR of 11.50% during the review period. Endoprosthesis is a treatment that includes utilizing an embed to supplant a joint in the body that has lost working capacities because of harm or disease. Degenerative joint sickness, cracks, and malignancies are for the most part normal signs that an endoprosthesis ought to be utilized.

The global endoprosthesis market accounted for USD 20,679.25 million in 2020 and is estimated to surpass USD 45,134.19 million by 2027. The expansion of the global endoprosthesis market is attributed to the elements like the expanding pervasiveness of osteoarthritis among the geriatric populace, mechanical headways in endoprosthesis gadgets empowering successful treatment, and expanding mindfulness among the populace.

Besides, unfavourable impacts and significant expenses related to endoprosthesis and lack of healthcare infrastructure and unaffordability in emerging countries are set to limit the endoprosthesis market development in the future.

Market Segmentation

The global endoprosthesis market based on products has been classified as knee, Hip, Shoulder, Elbow, Finger or Hand, and Ancle or foot.
Based on product segment, the global market is segmented into the knee, hip, shoulder, elbow, finger/hand, and ankle/foot.

The knee segment is further classified into primary knee replacement, partial knee replacement, custom-made replacements, revision knee replacement, and tumor.

By hip segment, the global endoprosthesis market is segmented into primary hip replacement, partial hip replacement, revision hip replacement, tumor, and custom-made partial pelvic replacements.

Based on the shoulder, the global endoprosthesis market is dispersed into primary shoulder replacement, revision shoulder replacements, tumor, and custom-made replacements.

In terms of the elbow, the global endoprosthesis market is segregated into total elbow replacement, radial head replacement, tumor, and custom-made replacements.
By finger/hand, the global endoprosthesis market is classified into total wrist prosthesis, (Proximal Interphalangeal) PIP finger prosthesis, and Metacarpophalangeal (MCP) finger prosthesis.

In terms of ankle/foot, the global endoprosthesis market is divided into total ankle implant and great toe implant.

Regional Analysis

North America held the largest market share in 2020. In North America, the endoprosthesis market is driven by the expanding reception of in fact progressed medical care items in the region and rising joint inflammation cases.

As indicated by the information distributed in the Centers for Disease Control and Prevention (CDC), the extended commonness of US grown-ups who are relied upon to report specialist analyzed joint pain is 67 million of every 2020, and by 2030, the number is projected to arrive at 72 million.

Accordingly, the district will request a compelling endoprosthesis gadget to conquer this sickness trouble. This factor is additionally projected to drive market development.

South America has seen extensive development in the endoprosthesis market and held a portion of the overall industry of 14.6% in 2020. Across South America, endoprosthesis rehearses are completed in various clinical offices, for example, government-controlled research facilities.

Monetarily autonomous patients frequently pick private research facility treatment. Brazil is one of the significant nations involving the biggest portion of the overall industry in the South American endoprosthesis market.

Prominent Players

The Major Companies Covered in this Report are Johnson & JohnsonServices, Inc.(US), Zimmer Biomet HoldingsInc.(US), Stryker(US), Smith & Nephew (UK), CorinLtd(UK), MedactaInternational SA(Switzerland), Exactech, Inc.(US), MicroPortOrthopedics,Inc.(US), A. (Switzerland), BraunMelsungenAG (Germany), Total Ankle Replacement (STAR; Small Bone Innovations, Morrisville, US), INBONE (Wright Medical Technology, Arlington, US),

Agility (DePuy, Warsaw, US), and Salto Talaris (Tornier, Montbonnot, France).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Growing public awareness, and technological advancements in endoprosthesis devices are anticipated to fuel the growth of the global endoprosthesis market at a CAGR of 11.58% during the forecast period of 2021 to 2027

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 2.5 ASSUMPTIONS & LIMITATIONS 3 RESEARCH METHODOLOGY 3.1 DATA MINING 3.2 SECONDARY RESEARCH 3.3 PRIMARY RESEARCH 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 3.5 FORECASTING TECHNIQUES 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 3.6.1 BOTTOM-UP APPROACH 3.6.2 TOP-DOWN APPROACH 3.7 DATA TRIANGULATION 3.8 VALIDATION 4 MARKET DYNAMICS 4.1 OVERVIEW 4.2 DRIVERS 4.2.1 INCREASING PREVALENCE OF OSTEOARTHRITIS AMONG THE GERIATRIC POPULATION 4.2.2 INCREASED INCIDENCES OF BONE FRACTURES 4.2.3 TECHNOLOGICAL ADVANCEMENTS IN ENDOPROSTHESIS DEVICES ENABLING EFFECTIVE TREATMENT 4.2.4 GROWING AWARENESS AMONG POPULATION 4.3 RESTRAINTS 4.3.1 ADVERSE EFFECTS ASSOCIATED WITH ENDOPROSTHESIS POST SURGERY 4.3.2 LACK OF HEALTHCARE INFRASTRUCTURE AND UNAFFORDABILITY IN EMERGING COUNTRIES 4.3.3 RESTRAINT IMPACT ANALYSIS 4.4 OPPORTUNITIES 4.4.1 RISING R&D INVESTMENTS FOR ENDOPROSTHESIS 4.4.2 INCREASING NUMBER OF PRODUCT LAUNCH, MERGER & ACQUISITION, AND EXPANSION 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 R&D 5.1.2 MANUFACTURING 5.1.3 DISTRIBUTION AND SALES 5.1.4 POST-SALES MONITORING 5.2 PORTER'S FIVE FORCES MODEL 5.2.1 BARGAINING POWER OF SUPPLIERS 5.2.2 BARGAINING POWER OF BUYERS 5.2.3 THREAT OF NEW ENTRANTS 5.2.4 THREAT OF SUBSTITUTES 5.2.5 INTENSITY OF RIVALRY 5.3 IMPACT OF COVID-19 ON THE ENDOPROSTHESIS MARKET 5.3.1 OVERVIEW 5.3.2 IMPACT ON SUPPLY CHAIN 5.3.3 IMPACT ON MARKET 5.3.4 DEMAND-SUPPLY GAP ANALYSIS 6 GLOBAL ENDOPROSTHESIS MARKET BY PRODUCT 6.1 OVERVIEW 6.2 KNEE 6.3 HIP 6.4 SHOULDER 6.5 ELBOW 6.6 FINGER/HAND 6.7 ANKLE/FOOT 7 GLOBAL ENDOPROSTHESIS MARKET BY KNEE 7.1 OVERVIEW 7.2 PRIMARY KNEE REPLACEMENT 7.2.1 PRIMARY CEMENTED KNEE REPLACEMENT 7.2.2 PRIMARY CEMENTLESS KNEE REPLACEMENT 7.2.3 PRIMARY HYBRID KNEE REPLACEMENT 7.2.4 BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT 7.2.4.1 PATELLA RESURFACING 7.2.4.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT 7.2.4.3 UNCOATED KNEE REPLACEMENT 7.2.4.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E) 7.2.5 MOBILE-BEARING 7.2.6 FIXED-BEARING 7.2.6.1 FIXED-BEARING WITH CEMENTED STEM 7.2.6.2 OTHERS 7.2.7 POSTERIOR STABILIZED 7.2.8 CRUCIATE-RETAINING 7.2.8.1 ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING 7.2.8.2 LATERAL PIVOT 7.2.8.3 MEDIAL PIVOT 7.3 PARTIAL KNEE REPLACEMENT 7.3.1 UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT 7.3.2 BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT 7.3.3 PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT 7.3.3.1 PATELLA RESURFACING 7.3.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT 7.3.3.3 UNCOATED KNEE REPLACEMENT 7.3.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E) 7.4 REVISION KNEE REPLACEMENT 7.4.1 COMPLETE NON-HINGED REVISION KNEE REPLACEMENT 7.4.2 COMPLETE HINGED REVISION KNEE REPLACEMENT 7.4.3 PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT 7.4.3.1 PATELLA RESURFACING 7.4.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT 7.4.3.3 UNCOATED KNEE REPLACEMENT 7.4.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E) 7.4.3.5 DEFECT FILLER (METAPHYSEAL) 7.5 TUMOR 7.5.1 PROXIMAL TIBIA REPLACEMENT 7.5.2 DISTAL FEMUR REPLACEMENT 7.6 CUSTOM MADE REPLACEMENT 7.6.1 GROWING PROSTHESIS 8 GLOBAL ENDOPROSTHESIS MARKET BY HIP 8.1 OVERVIEW 8.2 PRIMARY HIP REPLACEMENT 8.2.1 PRIMARY CEMENTED HIP REPLACEMENT 8.2.2 PRIMARY CEMENTLESS HIP REPLACEMENT 8.2.3 PRIMARY HYBRID HIP REPLACEMENT 8.2.3.1 DUAL MOBILITY CUP CEMENTED 8.2.3.2 DUAL MOBILITY CUP CEMENTLESS 8.2.4 HIP RESURFACING 8.2.5 TOTAL HIP RESURFACING 8.2.6 HEMI HIP RESURFACING 8.3 PARTIAL HIP REPLACEMENT 8.3.1 BIPOLAR PARTIAL HIP REPLACEMENT 8.3.2 UNIPOLAR PARTIAL HIP REPLACEMENT 8.3.3 ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT 8.4 CUSTOM HIP REPLACEMENTS 8.5 REVISION HIP REPLACEMENT 8.5.1 COMPLETE HIP REVISION 8.5.1.1 COMPLETE HIP REVISION WITH DUAL MOBILITY CUP 8.5.2 ACETABULAR COMPONENT REVISION 8.5.2.1 ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP 8.5.3 FEMORAL STEM REVISION 8.5.4 OTHER HIP REVISION 8.6 TUMOR 8.6.1 PROXIMAL FEMUR REPLACEMENT 9 GLOBAL ENDOPROSTHESIS MARKET BY SHOULDER 9.1 OVERVIEW 9.2 PRIMARY SHOULDER REPLACEMENT 9.2.1 PARTIAL SHOULDER REPLACEMENT 9.2.2 TOTAL/PRIMARY SHOULDER REPLACEMENT 9.2.3 REVERSE SHOULDER REPLACEMENT 9.2.4 SHOULDER RESURFACING 9.3 REVISION SHOULDER REPLACEMENTS 9.4 TUMOR 9.4.1 PROXIMAL HUMERUS REPLACEMENT 9.5 CUSTOM MADE REPLACEMENTS 10 GLOBAL ENDOPROSTHESIS MARKET BY ELBOW 10.1 OVERVIEW 10.2 TOTAL ELBOW REPLACEMENT 10.3 RADIAL HEAD REPLACEMENT 10.4 TUMOR 10.4.1 PROXIMAL ULNA REPLACEMENT 10.4.2 DISTAL HUMERUS REPLACEMENT 10.5 CUSTOM MADE REPLACEMENTS 11 GLOBAL ENDOPROSTHESIS MARKET BY FINGER/HAND 11.1 OVERVIEW 11.2 TOTAL WRIST PROTHESIS 11.3 PIP FINGER PROSTHESIS 11.4 MCP FINGER PROSTHESIS 11.4.1 CARPOMETACARPAL JOINT PROSTHESIS 11.4.2 OTHERS 12 GLOBAL ENDOPROSTHESIS MARKET BY ANKLE/FOOT 12.1 OVERVIEW 12.2 TOTAL ANKLE 12.3 GREAT TOE IMPLANT 13 GLOBAL ENDOPROSTHESIS MARKET, BY REGION 13.1 OVERVIEW 13.2 NORTH AMERICA 13.2.1 US 13.2.2 CANADA 13.2.3 MEXICO 13.3 SOUTH AMERICA 13.3.1 ARGENTINA 13.3.2 BRAZIL 13.3.3 COLOMBIA 13.3.4 PERU 13.3.5 CHILE 13.3.6 ECUADOR 13.3.7 REST OF SOUTH AMERICA 13.4 EUROPE 13.4.1 GERMANY 13.4.2 AUSTRIA 13.4.3 SWISS 13.4.4 FINLAND 13.4.5 DENMARK 13.4.6 NORWAY 13.4.7 SWEDEN 13.4.8 BELGIUM 13.4.9 FRANCE 13.4.10 NETHERLANDS 13.4.11 GREAT BRITAIN 13.4.12 CZECHIA 13.4.13 ITALIA 13.4.14 SPAIN 13.4.15 HUNGARY 13.4.16 IRELAND 13.4.17 PORTUGAL 13.4.18 POLAND 13.4.19 RUSSIA 13.4.20 ROMANIA 13.4.21 TURKEY 13.4.22 REST OF EUROPE 13.5 ASIA-PACIFIC 13.5.1 CHINA 13.5.2 JAPAN 13.5.3 INDIA 13.5.4 AUSTRALIA 13.5.5 SOUTH KOREA 13.5.6 TAIWAN 13.5.7 NEW ZEALAND 13.5.8 REST OF ASIA-PACIFIC 13.6 MIDDLE EAST & AFRICA 13.6.1 SAUDI ARABIA 13.6.2 UAE 13.6.3 EGYPT 13.6.4 ISRAEL 13.6.5 SOUTH AFRICA 13.6.6 SYRIA 13.6.7 REST OF MEA 14 COMPETITIVE LANDSCAPE 14.1 COMPETITIVEOVERVIEW 14.2 MAJOR PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET 14.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL ENDOPROSTHESIS MARKET 14.4 COMPETITIVE BENCHMARKING 14.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ENDOPROSTHESIS MARKET 14.6 KEY DEVELOPMENT ANALYSIS 14.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 14.7.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES 14.7.2 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES 14.8 MAJOR PLAYERS FINANCIAL MATRIX 14.8.1 REVENUE OF MAJOR PLAYERS 14.8.2 R&D EXPENDITURE 15 COMPANY PROFILES 15.1 JOHNSON & JOHNSON SERVICES, INC. 15.1.1 COMPANY OVERVIEW 15.1.2 FINANCIAL OVERVIEW 15.1.3 PRODUCTS/SERVICES OFFERED 15.1.4 KEY DEVELOPMENTS 15.1.5 SWOT ANALYSIS 15.1.6 KEY STRATEGIES 15.2 ZIMMER BIOMET HOLDINGS INC. 15.2.1 COMPANY OVERVIEWS 15.2.2 FINANCIAL OVERVIEW 15.2.3 PRODUCTS/SERVICES OFFERED 15.2.4 KEY DEVELOPMENTS 15.2.5 SWOT ANALYSIS 15.2.6 KEY STRATEGIES 15.3 STRYKER 15.3.1 COMPANY OVERVIEW 15.3.2 FINANCIAL OVERVIEW 15.3.3 PRODUCTS/SERVICES OFFERED 15.3.4 KEY DEVELOPMENTS 15.3.5 SWOT ANALYSIS 15.3.6 KEY STRATEGIES 15.4 SMITH AND NEPHEW 15.4.1 COMPANY OVERVIEW 15.4.2 FINANCIAL OVERVIEW 15.4.3 PRODUCTS/SERVICES OFFERED 15.4.4 KEY DEVELOPMENTS 15.4.5 SWOT ANALYSIS 15.4.6 KEY STRATEGIES 15.5 WALDEMAR LINK GMBH & CO. KG 15.5.1 COMPANY OVERVIEW 15.5.2 FINANCIAL OVERVIEW 15.5.3 PRODUCTS/SERVICES OFFERED 15.5.4 KEY DEVELOPMENTS 15.5.5 SWOT ANALYSIS 15.5.6 KEY STRATEGIES 15.6 LIMACORPORATE SPA. 15.6.1 COMPANY OVERVIEW 15.6.2 FINANCIAL OVERVIEW 15.6.3 PRODUCTS/SERVICES OFFERED 15.6.4 KEY DEVELOPMENTS 15.6.5 SWOT ANALYSIS 15.6.6 KEY STRATEGIES 15.7 CORIN LTD 15.7.1 COMPANY OVERVIEW 15.7.2 FINANCIAL OVERVIEW 15.7.3 PRODUCTS OFFERED 15.7.4 KEY DEVELOPMENTS 15.7.5 SWOT ANALYSIS 15.7.6 KEY STRATEGIES 15.8 PETER BREHM GMBH 15.8.1 COMPANY OVERVIEW 15.8.2 FINANCIAL OVERVIEW 15.8.3 PRODUCTS OFFERED 15.8.4 KEY DEVELOPMENTS 15.8.5 SWOT ANALYSIS 15.8.6 KEY STRATEGIES 15.9 MATHYS LTD BETTLACH 15.9.1 COMPANY OVERVIEW 15.9.2 FINANCIAL OVERVIEW 15.9.3 PRODUCTS OFFERED 15.9.4 KEY DEVELOPMENTS 15.9.5 SWOT ANALYSIS 15.9.6 KEY STRATEGIES 15.10 B. BRAUN MELSUNGEN AG 15.10.1 COMPANY OVERVIEW 15.10.2 FINANCIAL OVERVIEW 15.10.3 PRODUCTS OFFERED 15.10.4 KEY DEVELOPMENTS 15.10.5 SWOT ANALYSIS 15.10.6 KEY STRATEGIES 15.11 MEDACTA INTERNATIONAL SA 15.11.1 COMPANY OVERVIEW 15.11.2 FINANCIAL OVERVIEW 15.11.3 PRODUCTS/SERVICES OFFERED 15.11.4 KEY DEVELOPMENTS 15.11.5 SWOT ANALYSIS 15.11.6 KEY STRATEGIES 15.12 EXACTECH, INC. 15.12.1 COMPANY OVERVIEW 15.12.2 FINANCIAL OVERVIEW 15.12.3 PRODUCTS OFFERED 15.12.4 KEY DEVELOPMENTS 15.12.5 SWOT ANALYSIS 15.12.6 KEY STRATEGIES 15.13 MICROPORT ORTHOPEDICS, INC. 15.13.1 COMPANY OVERVIEW 15.13.2 FINANCIAL OVERVIEW 15.13.3 PRODUCTS OFFERED 15.13.4 KEY DEVELOPMENTS 15.13.5 SWOT ANALYSIS 15.13.6 KEY STRATEGIES 15.14 TIPSAN 15.14.1 COMPANY OVERVIEW 15.14.2 FINANCIAL OVERVIEW 15.14.3 PRODUCTS OFFERED 15.14.4 KEY DEVELOPMENTS 15.14.5 SWOT ANALYSIS 15.14.6 KEY STRATEGIES 15.15 BAUMER SA. 15.15.1 COMPANY OVERVIEW 15.15.2 FINANCIAL OVERVIEW 15.15.3 PRODUCTS OFFERED 15.15.4 KEY DEVELOPMENTS 15.15.5 SWOT ANALYSIS 15.15.6 KEY STRATEGIES 15.16 IMPOL 15.16.1 COMPANY OVERVIEW 15.16.2 FINANCIAL OVERVIEW 15.16.3 PRODUCTS OFFERED 15.16.4 KEY DEVELOPMENTS 15.16.5 SWOT ANALYSIS 15.16.6 KEY STRATEGIES 15.17 GROUPE LEPINE 15.17.1 COMPANY OVERVIEW 15.17.2 FINANCIAL OVERVIEW 15.17.3 PRODUCTS OFFERED 15.17.4 KEY DEVELOPMENTS 15.17.5 SWOT ANALYSIS 15.17.6 KEY STRATEGIES 15.18 CONFORMIS 15.18.1 COMPANY OVERVIEW 15.18.2 FINANCIAL OVERVIEW 15.18.3 PRODUCTS OFFERED 15.18.4 KEY DEVELOPMENTS 15.18.5 SWOT ANALYSIS 15.18.6 KEY STRATEGIES 15.19 DJO 15.19.1 COMPANY OVERVIEW 15.19.2 FINANCIAL OVERVIEW 15.19.3 PRODUCTS OFFERED 15.19.4 KEY DEVELOPMENTS 15.19.5 SWOT ANALYSIS 15.19.6 KEY STRATEGIES 15.20 IMPLANTCAST 15.20.1 COMPANY OVERVIEW 15.20.2 FINANCIAL OVERVIEW 15.20.3 PRODUCTS OFFERED 15.20.4 KEY DEVELOPMENTS 15.20.5 SWOT ANALYSIS 15.20.6 KEY STRATEGIES 16 APPENDIX 16.1 REFERENCES 16.2 RELATED REPORTS

Related products